Article
Molecular characterization of MET fusions from a large real-world Chinese population: A multicenter study.
Cancer medicine - 1 Jul 2023
Xia Hui, Zhang Junhua, Chen Tong, Wang Mingzhao, Chen Dongna, Si Tongguo, Liu Yutao
Abstract excerpt
PURPOSE: MET is a notable driver gene in the diversity of aberrations with clinical relevance, including exon 14 skipping, copy number gain, point mutations, and gene fusions. Compared with the former two, MET fusions are severely under-reported, leaving a series of unanswered questions. In this study, we addressed this gap by characterizing MET fusions in a large, real-world Chinese cancer population. METHODS:...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.